Phase 1 Trial in Patients With Human Papillomavirus (HPV)-Associated Cancer

Clinical trial NCT05826275 · COMPLETED

Trial details

NCT number: NCT05826275
Sponsor: Toragen, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HPV Associated Cancers

Start date: 2023-06-20
Primary completion: 2025-05-28
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.